441
Views
11
CrossRef citations to date
0
Altmetric
Research Letter

Quantifying the effect of exenatide and insulin glargine on postprandial glucose excursions in patients with type 2 diabetes

, , , &
Pages 1395-1397 | Accepted 10 Mar 2008, Published online: 03 Apr 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Stephen L. Aronoff. (2017) Rationale for treatment options for mealtime glucose control in patients with type 2 diabetes. Postgraduate Medicine 129:2, pages 231-241.
Read now
John Gerich. (2013) Pathogenesis and management of postprandial hyperglycemia: role of incretin-based therapies. International Journal of General Medicine 6, pages 877-895.
Read now
Abd A Tahrani, Milan K Piya & Anthony H Barnett. (2008) Exenatide: incretin therapy for patients with Type 2 diabetes mellitus. Expert Review of Endocrinology & Metabolism 3:6, pages 671-690.
Read now

Articles from other publishers (8)

Ling Li, Tao Yang, Yaoming Xue, Pengfei Ruan, Juan Du, Yunguang Li, Xia Zhang, Nan Cui & Wenying Yang. (2021) Influence of Fasting Plasma Glucose Targets on Glycemic Variability in Chinese Participants With Type 2 Diabetes: A Post Hoc Analysis of the FPG GOAL Trial (BEYOND III). Advances in Therapy 39:1, pages 421-429.
Crossref
J. P. H. Wilding & S. C. Bain. (2016) Role of incretin-based therapies and sodium-glucose co-transporter-2 inhibitors as adjuncts to insulin therapy in Type 2 diabetes, with special reference to IDegLira. Diabetic Medicine 33:7, pages 864-876.
Crossref
Roger S. Mazze, Ellie S. Strock, Richard M. Bergenstal, Amy Criego, Robert Cuddihy, Oded Langer, Gregg D. Simonson & Margaret A. Powers. 2011. Staged Diabetes Management. Staged Diabetes Management 77 137 .
B. Guerci, S. Halimi, P. Gourdy & E. Disse. (2011) Diabète de type 2 après échec de multithérapie orale : critères décisionnels personnalisés pour l’intensification du traitement. Médecine des Maladies Métaboliques 5:6, pages 625-632.
Crossref
Riccardo Perfetti. (2011) Combining Basal Insulin Analogs with Glucagon-Like Peptide-1 Mimetics. Diabetes Technology & Therapeutics 13:9, pages 873-881.
Crossref
G. Schernthaner, B. Guerci, B. Gallwitz, L. Rose, C. Nicolay, P. Kraus & C. Kazda. (2010) Impact of postprandial and fasting glucose concentrations on HbA1c in patients with type 2 diabetes. Diabetes & Metabolism 36:5, pages 389-394.
Crossref
Abd A. Tahrani, Milan K. Piya, Amy Kennedy & Anthony H. Barnett. (2010) Glycaemic control in type 2 diabetes: Targets and new therapies. Pharmacology & Therapeutics 125:2, pages 328-361.
Crossref
S. L. Norris, N. Lee, S. Thakurta & B. K. S. Chan. (2009) Exenatide efficacy and safety: a systematic review. Diabetic Medicine 26:9, pages 837-846.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.